059: Identification of novel subtype-specific alterations as candidates for drug targets and characterization of intratumour genetic heterogeneity and its contribution to therapy resistance in high-grade serous ovarian cancer (HGSOC)
HIPO Investigator:
PD Dr. Frederik Marmé
Dr. Marc Zapatka
Prof. Dr. Peter Lichter
Dr. Martin Sprick
Prof. Dr. Andreas Trumpp
Prof. Peter Sinn
Dr. Monika Hämmerle
Prof. Dr. Barbara Burwinkel
Prof. Dr. Andreas Schneeweiss
Prof. Dr. Benedikt Brors
Entity: HGSOC